From our perspective: The U.S. drug supply chain and patient safety. From our perspective banner no text. Ilisa Bernstein, Pharm.D., J.D., Deputy Director of FDA's Center for Drug Evaluation and Research's Office of Compliance, shares her thoughts on the important role drug supply chain ...
Must See TV: ABC's 20/20 "Inside the World of Counterfeit Goods" http://p0.vresp.com/tAyXSt
Tonight, ABC's 20/20 will be airing a segment, at 10:00pm EST, entitled, “Inside the World of Counterfeit Goods” The show will focusing on items across the board – automotive, pharma, electronics, handbags, etc. To watch the 20/20 trailer, Click Here. Libby Baney, Executive Director for Alliance ...
A parallel importer has discovered counterfeits of AbbVie's blockbuster Humira in the German supply chain.
Rx-360 Creates Asia Working Group http://p0.vresp.com/f0HZq7
Rx-360 Establishes Asia Working Group - India Washington, D.C. – Rx-360, an international, non-profit supply chain consortium, announced today, the formation of the Rx-360 Asia Working Group – India. The Working Group will be led by Anish Swadi, Vice President, Business Development at Hikal, ...
My name is Muhammad Hamid Zaman and I am a Professor of Biomedical Engineering and International Health at Boston University. […]
Counterfeit drugs are a danger to consumers. Safemedicines.org is the homepage of the Partnership for Safe Medicines, a coalition of patient, physician, pharmacist, academic, and industry groups that work together to educated the public about counterfeit drugs, pharmaceutical, biologics, vaccines, and all other types of fakes and counterfeits. The site holds information on related issues like internet or online pharmacies which might sell counter...
Of the 31 drugs shortages listed in the last couple of months, Mylan was a producer of 9 of them and Teva of 5 and in two cases, they both produced the same drug, the supplies of which were limited in some fashion. And if Teva is able to convince Mylan to join forces, this kind of information will be crucial to a review by antitrust regulators.
Fake AIDS, TB and malaria meds causing thousands of deaths
Fake malaria, HIV/AIDS, malaria and TB drugs 'may be responsible for tens of thousands of deaths in poor countries.'
Concerns over data manipulation lands Chinese API maker with US FDA Warning
FDA uncovers yet another case of counterfeit Botox, while a fake of Gilead's HIV drug Viread is found in Germany.
A collection of articles and studies detail the "real and urgent" threat posed by fake or low-quality drugs for conditions such as malaria and tuberculosis.
Counterfeit Botox found in US: The outer carton is counterfeit, while the vial inside is labeled as a foreign version of Botox, which is not FDA-approved for sale in the United States. These products are being sold by unlicensed suppliers who are not part of the legitimate U.S. supply chain. FDA cannot confirm that the manufacture, quality, storage, and handling of these products follow U.S. standards. These fraudulent products are considered unsafe and should not be used.
FDA is alerting health care practitioners and the public that fraudulent versions of Botox that are not approved by the FDA are being sold to U.S. medical practices. The outer carton is counterfeit, while the vial inside is labeled as a foreign version of Botox, which is not FDA-approved for sale in the United States.
India has introduced controversial new serialisation and reporting requirements for pharmaceutical exports.
At the request of the U.S. Food and Drug Administration and the U.S. Attorney for the Southern District of Florida, U.S. Marshals seized unapproved prescription drug products valued at over $1,500,000 from Stratus Pharmaceuticals, Inc., of Miami, Florida. Stratus Pharmaceuticals marketed and distributed unapproved prescription drug products that were manufactured by Sonar Products, Inc., of Carlstadt, New Jersey.
FDA plans to station more food and drug inspectors in China has been stymied because it's unable to obtain enough needed visas.
Read the Article about Rx-360's Efforts in Combating Counterfeits in In-Pharmatechnologist http://p0.vresp.com/FTZ1v3
Fighting Fake Drugs About Patient Safety not Competitive Advantage. In-Pharmatechnologist published the following article and interview with Martin VanTrieste, Rx-360 Board Member and SVP of Quality at Amgen. Fighting drug fakers relies on collaboration according to supply chain security group ...
101 East investigates the multi-billion-dollar trade in counterfeit medicines, which is creating a global health crisis.